Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$251.82
-0.43%
Alpha Vantage · 10/30/2026
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+9.4%
3 months
+9.0%
6 months
+31.7%
1 year
+45.7%
Year to date
+47.5%
52-week range
$170.63 – $252.92
Latest reported period: Sep 30, 2026
Market cap
$27.71B
P/E
24.5
P/B
3.6
P/S
2.3
Revenue
$11.84B
Net income
$1.13B
Diluted EPS
10.04
Gross margin
33.10%
Net margin
9.50%
Return on equity
15.20%
Total debt
$6.29B
Cash
$797M
Free cash flow
$1.38B
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 30, 2026 | $3.1B | $312M | 33.60% | 10.10% | $445M |
| Jun 30, 2026 | $3.04B | $320M | 33.70% | 10.50% | $459M |
| Mar 31, 2026 | $2.9B | $252M | 32.50% | 8.70% | $164M |
| Dec 31, 2025 | $2.81B | $245M | 32.40% | 8.70% | $307M |
| Sep 30, 2025 | $2.82B | $245M | 33.70% | 8.70% | $419M |
| Jun 30, 2025 | $2.76B | $282M | 34.20% | 10.20% | $436M |
| Mar 31, 2025 | $2.65B | $220M | 32.50% | 8.30% | $197M |
| Dec 31, 2024 | $2.62B | $222M | 32.70% | 8.50% | $341M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
This article from Investing.com announces a Form 144 filing for Quest Diagnostics Inc., pertaining to transactions made on October 26th. It briefly mentions the company's stock symbol DGX and includes a Reuters copyright notice, but provides no further details on the nature of the filing.
Original sourceThis article announces the filing of Form 144 for Quest Diagnostics Inc. on October 26, 2026. Form 144 is a notice of the intent to sell restricted securities. The brief notice indicates a transaction involving DGX stock.
Original source